Inovio Pharmaceuticals Inc
F:GBMB
Inovio Pharmaceuticals Inc
F:GBMB
Price:
11.94
EUR
7.76%
Market Closed
Market Cap:
€22.6m
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
I
|
Inovio Pharmaceuticals Inc
F:GBMB
|
US |
|
Rex International Holding Ltd
OTC:REXHF
|
SG |
|
K
|
Koninklijke Philips NV
XHAM:PHI1
|
NL |
|
American Software Inc
NASDAQ:AMSWA
|
US |
|
Getty Realty Corp
F:GRL
|
US |
|
G
|
Gujarat Pipavav Port Ltd
BSE:533248
|
IN |
|
W
|
Wharf Holdings Ltd
HKEX:4
|
HK |
|
Accton Technology Corp
TWSE:2345
|
TW |
Wall St Price Targets
GBMB Price Targets Summary
Inovio Pharmaceuticals Inc
Inovio Pharmaceuticals Inc
Wall Street analysts forecast GBMB stock price to rise over the next 12 months.
According to Wall Street analysts, the average 1-year price target for GBMB is 51.42 EUR with a low forecast of 33.13 EUR and a high forecast of 76.53 EUR.
Lowest Forecast
Price Target
33.13
EUR
177% Upside
Average Forecast
Price Target
51.42
EUR
331% Upside
Highest Forecast
Price Target
76.53
EUR
541% Upside
Why do you have more estimates than other sites?
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is GBMB's stock price target?
Price Target
51.42
EUR
51.42
EUR
According to Wall Street analysts, the average 1-year price target for GBMB is 51.42 EUR with a low forecast of 33.13 EUR and a high forecast of 76.53 EUR.
What is the Revenue forecast for Inovio Pharmaceuticals Inc?
Projected CAGR
163%
163%
Over the last 13 years, the compound annual growth rate for Revenue has been -27%. The projected CAGR for the next 8 years is 163%.
